| Product Name | [Arg8]-Vasopressin (AVP) |
| Purity | HPLC>95% |
| Description | AVP have been identified as an important regulator of fluid and electrolyte homeostasis through its anti-diuretic action on the kidney, After myocardial infarction, plasma levels of [Arg8]-vasopressin rise to recover hemodynamics. |
| Storage | -20°C |
| References | Iwadate, M. et al. Eur. J. Biochem. 267, 4504 (2000); Creba, JA. et al. Biochem. J. 212, 733 (1983); Teranishi, Y. et al. Jpn. J. Pharmacol. 79, 251 (1999); Lankhuizen, I. et al. J. Cardiovasc. Pharmacol. 36, 38 (2000); Barthelmebs, M. et al. Eur. J. Pharmacol. 314, 325 (1996); Hashimoto, H. et al. Neuropeptides 12, 199 (1988); Gieldon, J. Comput. Aided Mol. Des. 15, 1085 (2001). |
| Molecular Weight | 1084.3 |
| Sequence (One-Letter Code) | CYFQNCPRG-NH2 (Disulfide bridge: 1-6) |
| Sequence (Three-Letter Code) | H - Cys - Tyr - Phe - Gln - Asn - Cys - Pro - Arg - Gly - NH2 (Disulfide bridge: 1 - 6) |
[Arg8]-Vasopressin (AVP)Admin2021-01-04T06:29:45+00:00
